GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **701 - 725** of **4050** in total

« First

‹ Prev

…

25

26

27

28

29

30

31

32

33

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID	Arbitrary Fluorescence Units (AFU) ▲
IgM	Patient 1	10	moderate	G32473MI	45
IgM	Patient 1	10	moderate	G38488WF	45
IgM	Patient 1	22	moderate	G00048MO	45
IgM	Patient 1	22	moderate	G82096UQ	45
IgM	Patient 1	6	moderate	G07483YN	45
IgM	Patient 1	6	moderate	G08520NM	45
IgM	Patient 1	6	moderate	G93351GM	45
IgG	Patient 2	15	mild	G03499BP	45
IgG	Patient 2	15	mild	G58969RU	45
IgG	Patient 2	24	mild	G16579HJ	45
IgG	Patient 2	24	mild	G66937TJ	45
IgM	Patient 2	15	mild	G00054MO	45
IgM	Patient 2	24	mild	G00065MO	45
IgM	Patient 2	24	mild	G76615YG	45
IgG	Patient 2	3	mild	G39023AU	45
IgM	Patient 2	3	mild	G02557XE	45
IgM	Patient 2	3	mild	G96881BQ	45
IgG	Patient 3	-180	mild	G10789DJ	45
IgG	Patient 3	-180	mild	G58547FH	45
IgG	Patient 3	-180	mild	G86541PE	45
IgG	Patient 3	11	mild	G14844CX	45
IgG	Patient 3	11	mild	G18057VI	45
IgG	Patient 3	11	mild	G24432YB	45
IgG	Patient 3	11	mild	G58969RU	45
IgG	Patient 3	11	mild	G90223GH	45